The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study

• Xiaochen Fei,
• Liancheng Fan,
• Wei Chen,
• Wei Chen,
• Yiming Gong,
• Xinxing Du,
• Yanqing Wang,
• Yinjie Zhu,
• Jiahua Pan,
• Fangqin Wang,
• Wanbing Zhao,
• Tongtong Liu,
• Yining Yang,
• Baijun Dong,
• Wei Xue

Affiliations

Xiaochen Fei

Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Liancheng Fan

Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Wei Chen

Department of Urology The First Affiliated Hospital of Wenzhou Medical University Zhejiang China

Wei Chen

Department of Urology Zhongshan Hospital Shanghai Medical College Fudan University Shanghai China

Yiming Gong

Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Xinxing Du

Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Yanqing Wang

Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Yinjie Zhu

Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Jiahua Pan

Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Fangqin Wang

GloriousMedTechnologyCo. Ltd Shanghai China

Wanbing Zhao

GloriousMedTechnologyCo. Ltd Shanghai China

Tongtong Liu

GloriousMedTechnologyCo. Ltd Shanghai China

Yining Yang

GloriousMedTechnologyCo. Ltd Shanghai China

Baijun Dong

Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Wei Xue

Department of Urology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China